These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28993326)

  • 1. A Dynamic Stress Model Explains the Delayed Drug Effect in Artemisinin Treatment of Plasmodium falciparum.
    Cao P; Klonis N; Zaloumis S; Dogovski C; Xie SC; Saralamba S; White LJ; Fowkes FJI; Tilley L; Simpson JA; McCaw JM
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artemisinin Action and Resistance in Plasmodium falciparum.
    Tilley L; Straimer J; Gnädig NF; Ralph SA; Fidock DA
    Trends Parasitol; 2016 Sep; 32(9):682-696. PubMed ID: 27289273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Split dosing of artemisinins does not improve antimalarial therapeutic efficacy.
    White NJ; Watson J; Ashley EA
    Sci Rep; 2017 Sep; 7(1):12132. PubMed ID: 28935919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahost modeling of artemisinin resistance in Plasmodium falciparum.
    Saralamba S; Pan-Ngum W; Maude RJ; Lee SJ; Tarning J; Lindegårdh N; Chotivanich K; Nosten F; Day NP; Socheat D; White NJ; Dondorp AM; White LJ
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):397-402. PubMed ID: 21173254
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Zaloumis SG; Cao P; Dini S; Davenport MP; Cromer D; Khoury DS; Fowkes FJI; McCaw JM; Simpson JA
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Multidrug Tolerance in Plasmodium falciparum by Extended Artemisinin Pressure.
    Ménard S; Ben Haddou T; Ramadani AP; Ariey F; Iriart X; Beghain J; Bouchier C; Witkowski B; Berry A; Mercereau-Puijalon O; Benoit-Vical F
    Emerg Infect Dis; 2015 Oct; 21(10):1733-41. PubMed ID: 26401601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challenges.
    Patel K; Simpson JA; Batty KT; Zaloumis S; Kirkpatrick CM
    Br J Clin Pharmacol; 2015 Jan; 79(1):97-107. PubMed ID: 24251882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying artemisinin resistance from parasite clearance half-life data with a simple Shiny web application.
    Tun STT; Lubell Y; Dondorp AM; Fieldman T; Tun KM; Celhay O; Chan XH; Saralamba S; White LJ
    PLoS One; 2017; 12(5):e0177840. PubMed ID: 28531230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.
    Woodrow CJ; White NJ
    FEMS Microbiol Rev; 2017 Jan; 41(1):34-48. PubMed ID: 27613271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host immunity to
    Ataide R; Ashley EA; Powell R; Chan JA; Malloy MJ; O'Flaherty K; Takashima E; Langer C; Tsuboi T; Dondorp AM; Day NP; Dhorda M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Beeson JG; Nosten F; Simpson JA; White NJ; Fowkes FJ
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3515-3520. PubMed ID: 28289193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of artemisinin.
    Gordi T; Xie R; Jusko WJ
    Br J Clin Pharmacol; 2005 Dec; 60(6):594-604. PubMed ID: 16305583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artemisinin resistance in Plasmodium falciparum malaria.
    Taylor SM; Juliano JJ; Meshnick SR
    N Engl J Med; 2009 Oct; 361(18):1807; author reply 1808. PubMed ID: 19864681
    [No Abstract]   [Full Text] [Related]  

  • 14.
    Agarwal P; Anvikar AR; Pillai CR; Srivastava K
    Indian J Med Res; 2017 Nov; 146(5):622-628. PubMed ID: 29512604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children.
    Muwanguzi J; Henriques G; Sawa P; Bousema T; Sutherland CJ; Beshir KB
    Malar J; 2016 Jan; 15():36. PubMed ID: 26801909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging artemisinin resistance in the border areas of Thailand.
    Na-Bangchang K; Karbwang J
    Expert Rev Clin Pharmacol; 2013 May; 6(3):307-22. PubMed ID: 23656342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implicating extracellular vesicles in Plasmodium falciparum artemisinin resistance development.
    Tandoh KZ; Wilson MD; Quashie NB; Duah-Quashie NO
    Traffic; 2021 Jun; 22(6):194-200. PubMed ID: 33860593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parasite Viability as a Superior Measure of Antimalarial Drug Activity in Humans.
    Rebelo M; Pawliw R; Gower J; Webb L; Mitchell H; Pava Z; Watts RE; Davenport MP; McCarthy JS; Khoury DS
    J Infect Dis; 2021 Jun; 223(12):2154-2163. PubMed ID: 33119072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemisinin resistance in Plasmodium falciparum malaria.
    Htut ZW
    N Engl J Med; 2009 Oct; 361(18):1807-8; author reply 1808. PubMed ID: 19877309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.